Tagrisso

lazertinib

JNJ

lung cancer

Tagrisso reaches OS endpoint in PhIII EGFR-mutated lung cancer trial

Endpoints

Thu, 03/9/23 - 10:00 am

Genprex to progress Phase I/II trial of non-small cell lung cancer therapy

Clinical Trials Arena

Tue, 08/16/22 - 12:15 pm

Best-selling Tagrisso further outpaces an upcoming J&J rival, winning approval in new NSCLC indication

AstraZeneca pushes forward with Tagrisso combos, touting PhII data with Hutchmed drug

Endpoints

Mon, 08/8/22 - 09:54 am

AstraZeneca staves off last Tagrisso copycat with settlement—for now

Fierce Pharma

Wed, 04/27/22 - 10:40 pm

Alembic Pharmaceuticals

generics

Endpoints

Mon, 12/21/20 - 10:59 am

JNJ

amivantamab

AstraZeneca’s Tagrisso Continues to Make Strides in Phase III Lung Cancer Trial

BioSpace

Tue, 09/22/20 - 11:10 am

#ESMO20: AstraZeneca burnishes Tagrisso's adjuvant NSCLC profile with 'unprecedented' reduction in brain mets. Can they win over skeptics?

Endpoints

Sat, 09/19/20 - 09:05 pm

Daiichi Sankyo, AstraZeneca collaborate to evaluate patritumab deruxtecan in combination with TAGRISSO in EGFR-mutated NSCLC

ESMO

Pharmaceutical Business Review

Fri, 08/7/20 - 11:10 am

Daiichi Sankyo

patritumab deruxtecan

In pilot of patient-reported outcomes project, FDA hopes to encourage ‘more rigorous’ data collection

clinical trials

Cut-price drug venture takes aim at Pfizer and Astrazeneca

EP Vantage

Fri, 07/24/20 - 09:27 am

MedCity News

Sun, 06/28/20 - 06:56 pm

ASCO 2020 round-up: Virtual conference still delivers the drama ASCO 2020 round-up: Virtual conference still delivers the drama

Pharmaforum

Fri, 06/5/20 - 10:30 am

AstraZeneca's Blockbuster Lung Cancer Drug Has a Huge Sales Boost Ahead

Motley Fool

Sat, 05/30/20 - 07:48 pm

AstraZeneca bid to expand lung cancer drug's use boosted by trial data

BioPharma Dive

Thu, 05/28/20 - 11:12 pm

AstraZeneca to unveil key data for cancer drugs at ASCO

Pharmaforum

Fri, 05/15/20 - 10:41 am

AstraZeneca stops lung cancer trial early, after star drug Tagrisso induces 'overwhelming' efficacy

Endpoints

Mon, 04/13/20 - 11:06 am

clinical trials

Lilly touts Cyramza lung cancer data, as AZ’s Tagrisso grows even more powerful

Fierce Pharma

Mon, 10/7/19 - 12:18 pm

ESMO: AstraZeneca eyes payer boost with Tagrisso's latest survival win

Fierce Pharma

Sun, 09/29/19 - 09:29 pm

AZ gets China nod for Tagrisso in first-line lung cancer

Pharmaforum

Wed, 09/4/19 - 11:22 am

China